[
ABSTRAKKontrasepsi oral menempati peringkat kedua metode kontrasepsi yang paling
banyak digunakan di Indonesia, namun tingkat putus obat akibat reaksi obat yang
tidak dikehendaki (ROTD) cukup tinggi (13,2%). Hanya sebagian kecil akseptor
(23,9%) yang diberikan informasi tentang hal yang dapat dilakukan jika mengalami
ROTD seperti pilihan kontrasepsi oral dengan progestin generasi terbaru yang
memiliki efek samping lebih rendah. Tujuan penelitian ini adalah membandingkan
ROTD dari pil kontrasepsi kombinasi yang berisi levonorgestrel (generasi kedua)
dengan desogestrel (generasi ketiga). Metode penelitian ini adalah potong lintang
komparatif dengan sampel yang diperoleh secara acak dari enam kelurahan di
kecamatan Sukmajaya Depok pada rentang waktu Agustus ? November 2015.
Pengambilan data dilakukan menggunakan metode wawancara. Sampel penelitian
adalah 60 akseptor kelompok levonorgestrel dan 40 akseptor kelompok desogestrel.
Keluhan ROTD meliputi perdarahan di luar menstruasi (16,7%;5%), sakit kepala
(16,7% ; 5%), mual/muntah (25% ; 0), nyeri payudara (13,3% ; 0), gangguan terkait
hubungan seksual (23,3% ; 7,5%), penambahan berat badan (35% ; 22,5%), jerawat
(3,3% ; 7,5%) dan chloasma (28,3% ; 5%). Proporsi kejadian tersebut secara
signifikan lebih tinggi pada kelompok levonorgestrel pada gangguan hubungan
seksual (OR 3,75, 95% CI : 1,003 ? 14,050, p = 0,039) dan chloasma (OR 7,51, 95%
CI : 1,629 ? 34,647, p = 0,004).
ABSTRACTOral contraceptive was second contraception method most widely used in Indonesia,but had high percentage rate (13,2%) of withdrawal due to adverse drug reactions(ADR). Only small portion users (23,9%) who had been provided information aboutother oral contraceptive with the newer progestin generation as alternative optionto minimize ADR. This study was conducted to compare prevalence of ADRbetween combined oral contraceptives contain levonorgestrel (second generation)and desogestrel (third generation) which expected to have less side effects. Studywas done as cross sectional comparative design with random sampling from usersin six villages in Sukmajaya district, Depok City. Data were collected by interview.Samples consists of 60 users of levonorgestrel and 40 users of desogestrel. ADRcomplaints include intermenstrual bleeding (16.7%; 5%), headache (16.7%; 5%),nausea/vomiting (25%; 0), breast tenderness (13.3%; 0), impaired sexualintercourse (23.3%; 7.5%), weight gain (35%; 22.5%), acne (3.3%; 7.5%) andchloasma (28.3%; 5%). The proportion of these events was significantly higher inthe group of levonorgestrel for impaired sexual intercourse (OR 3.75, 95% CI:1.003 to 14.050, p = 0.039) and chloasma (OR 7.51, 95% CI: 1.629 to 34.647, p =0.004).;Oral contraceptive was second contraception method most widely used in Indonesia,but had high percentage rate (13,2%) of withdrawal due to adverse drug reactions(ADR). Only small portion users (23,9%) who had been provided information aboutother oral contraceptive with the newer progestin generation as alternative optionto minimize ADR. This study was conducted to compare prevalence of ADRbetween combined oral contraceptives contain levonorgestrel (second generation)and desogestrel (third generation) which expected to have less side effects. Studywas done as cross sectional comparative design with random sampling from usersin six villages in Sukmajaya district, Depok City. Data were collected by interview.Samples consists of 60 users of levonorgestrel and 40 users of desogestrel. ADRcomplaints include intermenstrual bleeding (16.7%; 5%), headache (16.7%; 5%),nausea/vomiting (25%; 0), breast tenderness (13.3%; 0), impaired sexualintercourse (23.3%; 7.5%), weight gain (35%; 22.5%), acne (3.3%; 7.5%) andchloasma (28.3%; 5%). The proportion of these events was significantly higher inthe group of levonorgestrel for impaired sexual intercourse (OR 3.75, 95% CI:1.003 to 14.050, p = 0.039) and chloasma (OR 7.51, 95% CI: 1.629 to 34.647, p =0.004)., Oral contraceptive was second contraception method most widely used in Indonesia,but had high percentage rate (13,2%) of withdrawal due to adverse drug reactions(ADR). Only small portion users (23,9%) who had been provided information aboutother oral contraceptive with the newer progestin generation as alternative optionto minimize ADR. This study was conducted to compare prevalence of ADRbetween combined oral contraceptives contain levonorgestrel (second generation)and desogestrel (third generation) which expected to have less side effects. Studywas done as cross sectional comparative design with random sampling from usersin six villages in Sukmajaya district, Depok City. Data were collected by interview.Samples consists of 60 users of levonorgestrel and 40 users of desogestrel. ADRcomplaints include intermenstrual bleeding (16.7%; 5%), headache (16.7%; 5%),nausea/vomiting (25%; 0), breast tenderness (13.3%; 0), impaired sexualintercourse (23.3%; 7.5%), weight gain (35%; 22.5%), acne (3.3%; 7.5%) andchloasma (28.3%; 5%). The proportion of these events was significantly higher inthe group of levonorgestrel for impaired sexual intercourse (OR 3.75, 95% CI:1.003 to 14.050, p = 0.039) and chloasma (OR 7.51, 95% CI: 1.629 to 34.647, p =0.004).]